OTC Market Europe Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers OTC Pharmaceutical Companies is Segmented by Product Type (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals, and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Other Product Types), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels), and Geography (United Kingdom, Germany, Italy, France, Spain, and Rest of Europe). The report offers the market sizes and forecasts in terms of value (in USD million) for the above segments.

OTC Market Europe Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

OTC Europe Industry Overview

The European OTC market is highly competitive and consists of several major players. Most OTC products are generic drugs; thus, competitive advantage through product innovation is not possible, and major players primarily compete through product branding and competitive pricing practices. Companies like AstraZeneca, GlaxoSmithKline, Bayer, and Cardinal Health hold substantial shares in the European OTC drugs market.

OTC Europe Market Leaders

  1. Cardinal Health Inc.

  2. Bayer AG

  3. GlaxoSmithKline PLC

  4. Johnson & Johnson

  5. Novartis AG

  6. *Disclaimer: Major Players sorted in no particular order
Europe Over-the-Counter (OTC) Drugs Market Concentration

Europe OTC Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?